VectorBuilder offers gene delivery solutions, including vector design, cloning, and manufacturing services. The company focuses on research and clinical applications.

VectorBuilder

VectorBuilder | 5,052 followers on LinkedIn. VectorBuilder is a global leader in gene delivery technologies.  | As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.

VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy.

Territory manager

Sandra Akpe San Roman, PhD

Sr. Scientific Manager & Visiting Research Fellow at the University of Sussex

Paola Dama

Head of Global Operations - Cell & Gene Therapy | Gene Editing | Biomanufacturing | Synthetic Biology

Alan Griffith Ph.D

Vectorbuilder VP of Strategies

黄锐Nicholas

We're proud to announce that our Chief Scientist, Dr. Bruce Lahn has been recognized on the 2024 Forbes China 100 Most Influential Chinese list. 🏆🎉 This distinguished annual selection honors 100 prominent Chinese figures shaping business, culture, and philanthropy globally, with past recipients including NVIDIA 's Jensen Huang . Dr. Lahn was chosen for his pivotal contributions to advancing life sciences worldwide. 🌍✨ In 2014, Dr. Lahn’s entrepreneurial drive led him to launch VectorBuilder, an online platform that has revolutionized gene delivery. 🧬 By automating and simplifying the design and ordering of gene delivery vectors, VectorBuilder has streamlined research for hundreds of thousands of life science labs around the world. The platform’s innovation and impact are reflected in over 5,000 scientific publications, and VectorBuilder’s client base spans more than 4,500 institutions in 90+ countries, including 90% of the top 100 QS-ranked universities and 90% of the top 30 global pharmaceutical companies. 🔗 Read more about Dr. Bruce Lahn's contributions and journey: https://lnkd.in/dTg3awjs

We're Going LIVE! 🔴 Join Our Webinar to Discover the Power of Mini Plasmids: https://lnkd.in/eBgnnbUF 💪 Today at 11:00 AM ET, discover how new mini plasmid technology is addressing safety concerns and improving gene therapy outcomes in our upcoming webinar, "Improving Gene Therapy Safety with Antibiotic- and Supplement-Free Mini Plasmids."

Last Chance! Join Our Webinar to Discover the Power of Mini Plasmids 💪 Register: https://lnkd.in/eBgnnbUF This Thursday, discover how new mini plasmid technology is addressing safety concerns and improving gene therapy outcomes in our upcoming webinar, "Improving Gene Therapy Safety with Antibiotic- and Supplement-Free Mini Plasmids." In this webinar, our experts—Application Scientist Cole Cheng, PhD, and Scientific Product Manager Connie Rich, PhD—will reveal how antibiotic- and supplement-free miniaturized plasmids are transforming therapeutic development. 📅 Save the Date: Thursday, November 14, 2024 🕒 Time: 11:00 AM - 12:30 PM ET 📍 Format: Live and On-Demand Access Available Don’t miss out on this chance to learn about a safer, more effective approach to gene therapy. Reserve your spot today: https://lnkd.in/eBgnnbUF

Meet VectorBuilder at the LION conference in Leipzig and use this established event at the IZI to share and discuss your latest experimental findings in Immune Oncology.

Nadine Müller, PhD

Upcoming Conferences 📢 Nov 15 - 18, 2024 | AHA with Senior Territory Manager Jessi Toumeh , Scientific Liaison Croydon Fernandes, Lead Application Scientist Charles Xingjian Bai , Scientific Product Manager Brady Strittmatter Nov 17 - 20, 2024 | The 4th Metabolic Diseases Meeting with Associate Director Thomas Leung Nov 18 - 20, 2024 | ISNN (11th international Symposium on Neuroprotection and Neurorepair) with Territory Manager Nadine Müller, PhD Join us in the gene delivery revolution: https://lnkd.in/g45YDh2p 🧬

Are you attending the ASSCR 2024 meeting? We are here at the National Wine Centre of Australia, South Australia. Please come to our booth to chat with us for more details about our gene delivery solutions for stem cell research! VectorBuilder VectorBee

Thomas Leung

Meet our Business Development Account Specialist Maria Pascual, PhD at the X Latin American Symposium on Cell Culture Technology, a conference that allows you to share and discuss results and experiences in animal cell culture applications. #SLATCC 📌From 13 to 16 November 2024 📍Hotel Marina del Rey, Viña del Mar 📲Register: https://shorturl.at/CIVsq 🤝Organized by: School of Biochemical Engineering of the Pontificia Universidad Católica de Valparaíso, together with researchers from the University of Chile and the University of Concepción.

We had a great time presenting at #ASHG ! You can still meet us at Booth #860 to learn more about our poster “Prevalence of errors in lab-made plasmids across the globe,” as well as VectorBuilder 's extensive list of products and services! ✨ Join us in the gene delivery revolution: www.VectorBuilder.com 🧬 #ASHG2024 #ASHG24 #HumanGenetics

Are you at #ASHG right now? Come meet us at booth #860 🧬 Have a chat with Scientific Liaison Croydon Fernandes, Territory Manager Richard Nemeth Ph.D. , and Account Manager Anil Poudel to learn how VectorBuilder can revolutionize all your gene delivery needs. We’re also presenting Poster Board #1087W - “Prevalence of errors in lab-made plasmids across the globe” from 🕝 2:30pm - 4:30pm MT… so don’t miss out! Join us in the gene delivery revolution: www.VectorBuilder.com #ASHG2024 #ASHG24 #HumanGenetics

Metric
Company Name	VectorBuilder
Symbol
MSH ID	COM:VECTORBUILDER:EN
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage	Venture Round
Employee Count
Website	en.vectorbuilder.com
LinkedIn	vectorbuilder
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	59.91K
Web Traffic Growth	-0.25
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VECT

COM:VECTORBUILDER:EN

VectorBuilder

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue